Washington Amendment No. 2 to Registration Rights Agreement Visible Genetics, Inc. and the purchasers of common shares of the company have entered into the Washington Amendment No. 2 to Registration Rights Agreement to address certain amendments and updates to the original agreement. This amendment aims to provide additional rights and protections for the purchasers of Visible Genetics' common shares. The primary purpose of this amendment is to grant the purchasers certain rights related to the registration of their shares with the Securities and Exchange Commission (SEC). These rights ensure that the purchasers have the opportunity to publicly sell or transfer their shares in compliance with applicable regulations. This amendment specifies the registration requirements and procedures that both Visible Genetics, Inc. and the purchasers must follow. It stipulates the timeline and process for filing registration statements with the SEC and provides guidelines for the company's cooperation in the registration process. Additionally, Washington Amendment No. 2 may outline any limitations or restrictions on the purchasers' ability to sell or transfer their shares. These restrictions may include lock-up periods, which prevent shareholders from selling their shares for a certain period after an initial public offering (IPO) or other significant corporate events. Furthermore, this amendment may address any adjustments to the original registration rights agreement necessary due to changes in applicable laws or regulations. It ensures that the agreement remains in compliance with Washington state laws and any other relevant legal requirements. In summary, Washington Amendment No. 2 to the Registration Rights Agreement between Visible Genetics, Inc. and purchasers of common shares is designed to enhance the rights and protections of the shareholders. It governs the registration process, outlines any restrictions on share sales, and ensures compliance with applicable laws.